Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sequenom, Inc.
To collect specimens for the purpose of developing a prenatal aneuploidy test. The test will analyze circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have an increased risk indicator/s for fetal chromosomal aneuploidy and are undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS) and/or genetic amniocentesis. The results of the ccff aneuploidy test will be compared to the chromosomal analysis obtained via CVS or genetic amniocentesis.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
pregnant between 10 and 22 weeks gestation
18 years of age or older
provides signed and dated informed consent
subject is at increased risk for fetal aneuploidy
subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis
subject agrees to provide the genetic results of the invasive procedure
